Researchers at the Francis Crick Institute and Vividion Therapeutics have identified chemical compounds that can precisely block the interaction between the major cancer-driving gene RAS and a key pathway for tumor growth.
Oct 9, 2025
0
41
Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says.
Jan 29, 2025
0
31
A team of researchers at the University of Michigan Health Rogel Cancer Center has designed a molecule that impairs signaling mediated by two key drivers of cancer therapy resistance. The design and preclinical evaluation ...
Jul 29, 2024
0
66
Immunotherapies have been successful in treating many cancer conditions; however, not much success has yet been achieved in metastatic castrate-resistant prostate cancer (mCRPC). A study published March 2 in Clinical Cancer ...
Mar 3, 2023
0
66
A team of University of Michigan researchers is developing a new anti-cancer drug that is absorbed through the gut's lymphatic system rather than blood vessels, potentially outmaneuvering the molecular signaling pathways ...
Aug 17, 2022
0
134
Fucoidan, a kind of sulfated polysaccharide present in brown algae, is considered as a promising therapeutic agent because of its multiple bioactivities.
Jul 20, 2022
0
79
